Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (GREENFIELD)
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms GREENFIELD
- Sponsors Abbott Laboratories; AbbVie
- 31 Aug 2018 Biomarkers information updated
- 16 Jun 2016 Status changed from active, no longer recruiting to completed.
- 16 Nov 2014 Planned End Date changed from 1 Feb 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov record.